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TABLE 1. Stress and immunologic responsemarkers assessedat timed intervals fromtheprocedure
for spontaneous secondarypneumothorax inawakepatients (n¼ 14) andnonawake controls (n¼ 17)
Preoperative
Postoperative
12 h 24 h 48 h
Cortisol (mg/dL)
Awake 13 (8-17) 14 (9-18) 13 (8-18) 12 (9-15)
Control 14 (8-18) 23* (17-43) 21y (13-30) 18z (14-28)
P value .4 .02 .01 .05
Interleukin 6 (pg/mL)
Awake 3.5 (2.5-4.5) 80* (59-121) 61* (41-86) 10z (5-21)
Control 3.4 (2.4-3.8) 124* (82-177) 111* (88-153) 43* (22-91)
P value .5 .03 .01 .001
Natural killer lymphocytes (%)
Awake 11 (7-15) 10 (6-13) 10 (7-13) 11 (6-14)
Control 10 (5-15) 5* (2-7) 6y (3-9) 8z (4-10)
P value .4 .01 .02 .06
Values represent medians and interquartile ranges of unpublished data. *P .001 for intragroup significance versus
baseline value. yP .01 for intragroup significance versus baseline value. zP .05 for intragroup significance versus
baseline value.
Letters to the Editormeasurements of coronary blood flow,
regional myocardial blood flow,
systemic hemodynamics, and electro-
cardiography during different physio-
logic conditions confirmed that
coronary compression between the
great vessels produced myocardial is-
chemia. A clinical study is urgently
needed to replicate and clarify the im-
plications of this finding and to gener-
ate standardized treatments for
congenital coronary anomalies. Fi-
nally, we thank the editors of The Jour-
nal of Thoracic and Cardiovascular
Surgery for the opportunity to com-
ment on our work.
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FOR SECONDARY
SPONTANEOUS
PNEUMOTHORAX: ANOTHER
ADVANCEMENT
To the Editor:
With a great and renewed interest,
we read the recent article by Noda
and colleagues.1 They advocated the
usefulness of awake thoracoscopic sur-
gery in treatingpatientswith secondary
spontaneous pneumothorax, listing
various advantages in a total of 57 con-
secutive patients whom they treated.
These advantages compel us to answer
‘‘yes’’ to thequestion in the title of their
article, ‘‘Is there a benefit of awake
thoracoscopic surgery in patients with
secondary spontaneous pneumotho-
rax?’’ Noda and colleagues1of Thoracic and Cardiovascular Surgerappropriately deserve credit for this
growing experience in awake surgery.
In our own personal experience, the
awake surgical treatment of secondary
spontaneous pneumothorax has been
one of the most critical challenges, first
because of the severe and sometime le-
thal underlying lungdisease and second
because of thedeterioratedgeneral con-
dition of the patients, which often
makes them surgically untreatable.
In this setting, we have recently
speculated on the biologic bases of
these clinical advantages. Indeed, our
preliminary observations have shown
that awake procedures may attenuate
the release of stress hormones (corti-
sol) and systemic inflammation bio-
markers (interleukin 6) and preserve
natural killer cell proportion from
the early postoperative period onward
(Table 1). The impairment of immune
function may lead to several adverse
effects, including postoperative infec-
tions, thus explaining better clinical
results seen after awake surgery.
With attention to the particular medi-
cal needs of our patients,we offer awake
surgery and follow the preference of the
patient after adequate information about
technical aspects of the procedure.
Nowadays, we see favorable satisfac-
tion with the procedure among both pa-
tients and referring physicians.y c Volume 144, Number 6 1533
Letters to the EditorStarting from January 2001,we have
established a structured program ap-
proved by the research ethics board of
our academic Institution.2 After more
than a decade of experience,3-5 we
believe that a surgeon should awarded
privileges in performing a regular
number of such procedures by the
institution administrators. We suggest
that proficiency in awake thoracic
surgery be certified and listed as
a credential in submitting applications
for surgical positions. Certification in
awake surgery should be also given to
operating room staff, including
dedicated thoracic anesthesiologists,
scrub nurses, and technicians.
Commitment to maintain the same
team for at least 40 procedures a year
should be also provided.
It is nice for us to read favorable
and more frequent studies about this
awake anesthesiology pattern. We
therefore encourage thoracic sur-
geons to perform these procedures
and submit their statistics to an insti-
tutional database, thus providing an
excellent tool for evidence-based sur-
gery. Those educational centers
where this modern program is adop-
ted should establish cooperative net-
works with each other and should
accurately popularize the benefits of
the treatment among physicians and
patients. In addition, such educa-
tional tools as dry and wet labs, oper-
ating room simulations and lecture
series should form an active part of
this program. Finally, to conduct
a successful and safe awake thoracic
operation, the surgeon must be aware
of both short- and long-term out-
comes and must be updated with
the latest advances in this field.
In the end, we are firmly convinced
that this field of surgery is ripe for fur-
ther developments.
Tommaso Claudio Mineo, MD
Vincenzo Ambrogi, MD, PhD
Department of Thoracic Surgery
Policlinico Tor Vergata
University Tor Vergata of Rome
Rome, Italy1534 The Journal of Thoracic andReferences
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IN COMPLEX AORTIC
SURGERY: A ROLE FOR
MULTIPLE ELECTRODE
AGGREGOMETRYAND
MODIFIED ROTATIONAL
THROMBOELASTOMETRY
To the Editor:
We read with a great interest the
recently published retrospective
propensity-matched analysis by
Goksedef and colleagues,1 who
matched 58 cardiac surgical patients
in a recombinant activated factor VII
(rFVIIa)–treated group (n ¼ 29) and
a control group (n ¼ 29). Patients
were compared with respect to reex-
ploration, mortality, bleeding-related
events, use of blood and blood prod-
ucts, duration of intensive care unit
stay, duration of hospitalization, and
thrombotic complications.1 We agree
with the statement of Goksedef and
colleagues1 that strategies to prevent
coagulopathic bleeding are essential
for the successful management of
patients undergoing complex aortic
operations. We do, however, have
a few comments and suggestions for
hemostatic management in such com-
plex cases.
In our opinion, data regarding pre-
operative antiplatelet therapy
management are lacking. We are in-
terested to know whether matchedCardiovascular Surgery c December 20patients were preoperatively exposed
to antiplatelet therapy (eg, aspirin).
Was the proportion of patients ex-
posed to antiplatelet therapy different
among the matched groups? There is
some evidence that certain patients
have an accentuated response to the
usual doses of preoperative aspirin
that may result in increased perioper-
ative blood loss.2 The use of suitable
point-of-care platelet function ana-
lyzers thus seems to be reasonable
in this field. Such an approach in
the preoperative phase can discrimi-
nate patients with accentuated plate-
let inhibition and allow the
possibility of early discontinuation
of antiplatelet drugs before surgery
for patients with intensive platelet
inhibition.
Furthermore, the results of the
study by Goksedef and colleaguesl1
are not in line with recently published
results by Chapman and coworkers,3
who also compared cardiac surgical
patient outcomes with respect to
rFVIIa administration. In the study
by Chapman and coworkers,3 a group
of patients treated with rFVIIa did
have significantly higher rate of reop-
eration for bleeding, a 2-fold increase
in the use of blood products, and more
frequent pulmonary complications. In
addition to this, Hacquard and associ-
ates4 reported that 20% of patients
who received rFVIIa continued to
bleed severely despite the rFVIIa
therapy.
In our opinion, rFVIIa represents
a valuable therapeutic option in cases
of intractable bleeding; however, it
should be administered after other
useful treatment modalities have
been exhausted. For example, Spiess
and coworkers5 reported that throm-
boelastographically guided hemo-
static management significantly
reduced both overall transfusion and
mediastinal reexploration for
excessive bleeding. In addition, the
preliminary results of our research
project (under clinicaltrials.gov
identifier NCT01281397; data not12
